{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:01:45Z","timestamp":1782846105913,"version":"3.54.5"},"reference-count":33,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Med Inform"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pulmonary hypertension (PH) is a progressive disorder characterized by elevated pulmonary artery pressure and increased pulmonary vascular resistance, ultimately leading to right heart failure. Early detection is critical for improving patient outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The diagnosis of PH primarily relies on right heart catheterization, but its invasive nature significantly limits its clinical use. Echocardiography, as the most common noninvasive screening and diagnostic tool for PH, provides valuable patient information. This study aims to identify key PH predictors from echocardiographic parameters, laboratory tests, and demographic data using machine learning, ultimately constructing a predictive model to support early noninvasive diagnosis of PH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study compiled comprehensive datasets comprising echocardiography measurements, clinical laboratory data, and fundamental demographic information from patients with PH and matched controls. The final analytical cohort consisted of 895 participants with 85 evaluated variables. Recursive feature elimination was used to select the most relevant echocardiographic variables, which were subsequently integrated into a composite ultrasound index using machine learning techniques, XGBoost (Extreme Gradient Boosting). LASSO (least absolute shrinkage and selection operator) regression was applied to select the potential predictive variable from laboratory tests. Then, the ultrasound index variables and selected laboratory tests were combined to construct a logistic regression model for the predictive diagnosis of PH. The model\u2019s performance was rigorously evaluated using receiver operating characteristic curves, calibration plots, and decision curve analysis to ensure its clinical relevance and accuracy. Both internal and external validation were used to assess the performance of the constructed model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 16 echocardiographic parameters (right atrium diameter, pulmonary artery diameter, left atrium diameter, tricuspid valve reflux degree, right ventricular diameter, E\/E\u2019 [ratio of mitral valve early diastolic inflow velocity (E) to mitral annulus early diastolic velocity (E\u2019)], interventricular septal thickness, left ventricular diameter, ascending aortic diameter, left ventricular ejection fraction, left ventricular outflow tract velocity, mitral valve reflux degree, pulmonary valve outflow velocity, mitral valve inflow velocity, aortic valve reflux degree, and left ventricular posterior wall thickness) combined with 2 laboratory biomarkers (prothrombin time activity and cystatin C) were identified as optimal predictors, forming a high-performance PH prediction model. The diagnostic model demonstrated high predictive accuracy, with an area under the receiver operating characteristic curve of 0.997 in the internal validation and 0.974 in the external validation. Both calibration plots and decision curve analysis validated the model\u2019s predictive accuracy and clinical applicability, with optimal performance observed at higher risk stratification cutoffs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This model enhances early PH diagnosis through a noninvasive approach and demonstrates strong predictive accuracy. It facilitates early intervention and personalized treatment, with potential applications in broader cardiovascular disease management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/74117","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T14:35:08Z","timestamp":1755268508000},"page":"e74117-e74117","source":"Crossref","is-referenced-by-count":3,"title":["Interpretable Machine Learning Model for Pulmonary Hypertension Risk Prediction: Retrospective Cohort Study"],"prefix":"10.2196","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9009-6779","authenticated-orcid":false,"given":"Hongxia","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4575-2671","authenticated-orcid":false,"given":"Han","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0965-5425","authenticated-orcid":false,"given":"Dexin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4507-7151","authenticated-orcid":false,"given":"Qingli","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2582-3122","authenticated-orcid":false,"given":"Xiaojun","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7387-496X","authenticated-orcid":false,"given":"Zhenshun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"issue":"9","key":"R1","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S2213-2600(23)00264-3","article-title":"Treatment of pulmonary arterial hypertension: recent progress and a look to the future","volume":"11","author":"Humbert","journal-title":"Lancet Respir Med"},{"issue":"5","key":"R2","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1164\/rccm.202302-0327SO","article-title":"Pulmonary hypertension: a contemporary review","volume":"208","author":"Johnson","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"R3","doi-asserted-by":"publisher","first-page":"2301633","DOI":"10.1183\/13993003.01633-2023","article-title":"Phenotypes in pulmonary hypertension","volume":"64","author":"Weatherald","journal-title":"Eur Respir J"},{"issue":"9","key":"R4","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S2213-2600(20)30317-9","article-title":"Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study","volume":"8","author":"Maron","journal-title":"Lancet Respir Med"},{"issue":"1","key":"R5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.chest.2022.01.031","article-title":"Severe pulmonary hypertension in COPD: impact on survival and diagnostic approach","volume":"162","author":"Kovacs","journal-title":"Chest"},{"issue":"5","key":"R6","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.chest.2022.12.045","article-title":"Derivation of a risk score (REVEAL-ECHO) based on echocardiographic parameters of patients with pulmonary arterial hypertension","volume":"163","author":"El-Kersh","journal-title":"Chest"},{"issue":"1","key":"R7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01900-2018","article-title":"Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update","volume":"53","author":"Noordegraaf","journal-title":"Eur Respir J"},{"issue":"48","key":"R8","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3238\/arztebl.m2023.0222","article-title":"The early detection of pulmonary hypertension","volume":"120","author":"Ley","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"R9","doi-asserted-by":"publisher","DOI":"10.1002\/pul2.12361","article-title":"Identifying consistent echocardiographic thresholds for risk stratification in pulmonary arterial hypertension","volume":"14","author":"Celestin","journal-title":"Pulm Circ"},{"issue":"23","key":"R10","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1016\/j.jacc.2019.09.063","article-title":"Echocardiographic features of patients with heart failure and preserved left ventricular ejection fraction","volume":"74","author":"Shah","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"R11","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003674","article-title":"Prevalence, risk factors and echocardiographic predictors of pulmonary hypertension in systemic lupus erythematosus: towards a screening protocol","volume":"10","author":"Troncoso","journal-title":"RMD Open"},{"issue":"5","key":"R12","doi-asserted-by":"publisher","DOI":"10.1111\/anec.13133","article-title":"Establishment of a prediction model of pulmonary artery hypertension in patients with hyperthyroidism","volume":"29","author":"Yan","journal-title":"Noninvasive Electrocardiol"},{"issue":"9","key":"R13","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.032412","article-title":"Development and validation of a nomogram of persistent pulmonary hypertension in adult pretricuspid shunts after correction","volume":"13","author":"Zhou","journal-title":"JAHA"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.2147\/NSS.S372447","article-title":"Development and validation of a nomogram for predicting obstructive sleep apnea in patients with pulmonary arterial hypertension","volume":"14","author":"Hu","journal-title":"NSS"},{"issue":"5","key":"R15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i05","article-title":"Building predictive models in R using the caret package","volume":"28","author":"Kuhn","journal-title":"J Stat Soft"},{"key":"R16","unstructured":"Pulmonary hypertension risk prediction nomogram. PH Risk Nomogram. URL: https:\/\/jianghx.shinyapps.io\/PHpredictor\/ [Accessed 16-09-2025]"},{"issue":"1","key":"R17","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1080\/10717544.2021.1927243","article-title":"Efficacy and safety of novel-targeted drugs in the treatment of pulmonary arterial hypertension: a Bayesian network meta-analysis","volume":"28","author":"Fu","journal-title":"Drug Deliv (Lond)"},{"issue":"12","key":"R18","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1164\/rccm.202012-4317SO","article-title":"Pulmonary arterial hypertension: diagnosis, treatment, and novel advances","volume":"203","author":"Maron","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"R19","doi-asserted-by":"publisher","first-page":"ITC49","DOI":"10.7326\/AITC202104200","article-title":"Pulmonary hypertension","volume":"174","author":"Poch","journal-title":"Ann Intern Med"},{"issue":"9","key":"R20","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.mayocp.2020.04.039","article-title":"Pulmonary hypertension: a brief guide for clinicians","volume":"95","author":"Mandras","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"R21","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/eurheartj\/ehv512","article-title":"Left ventricular heart failure and pulmonary hypertension","volume":"37","author":"Rosenkranz","journal-title":"Eur Heart J"},{"issue":"12","key":"R22","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1093\/ehjci\/jex244","article-title":"Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging","volume":"18","author":"Galderisi","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2","key":"R23","first-page":"273","volume":"117","author":"Jones","journal-title":"Am J Pathol"},{"issue":"10","key":"R24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11906-023-01258-0","article-title":"Irregularities of coagulation in hypertension","volume":"25","author":"Rafaqat","journal-title":"Curr Hypertens Rep"},{"issue":"4","key":"R25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/resp.12259","article-title":"Cystatin C: a potential biomarker for pulmonary arterial hypertension","volume":"19","author":"Fenster","journal-title":"Respirology"},{"issue":"11","key":"R26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11906-022-01212-6","article-title":"Machine learning for hypertension prediction: a systematic review","volume":"24","author":"Silva","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"R27","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1186\/s12967-020-02620-5","article-title":"Predicting 30-days mortality for MIMIC-III patients with sepsis-3: a machine learning approach using XGboost","volume":"18","author":"Hou","journal-title":"J Transl Med"},{"issue":"1","key":"R28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1146\/annurev-pathol-042320-030240","article-title":"Pathogenic mechanisms underlying idiopathic pulmonary fibrosis","volume":"17","author":"Moss","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"8","key":"R29","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1136\/heartjnl-2023-323320","article-title":"Echocardiographic artificial intelligence for pulmonary hypertension classification","volume":"110","author":"Hirata","journal-title":"Heart"},{"issue":"5","key":"R30","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.amjcard.2018.05.019","article-title":"Clinical and echocardiographic predictors of outcomes in patients with pulmonary hypertension","volume":"122","author":"Siddiqui","journal-title":"Am J Cardiol"},{"issue":"2","key":"R31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.healun.2022.10.026","article-title":"Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension","volume":"42","author":"Hirsch","journal-title":"J Heart Lung Transplant"},{"issue":"9","key":"R32","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.119.009047","article-title":"Validation of the tricuspid annular plane systolic excursion\/systolic pulmonary artery pressure ratio for the assessment of right ventricular-arterial coupling in severe pulmonary hypertension","volume":"12","author":"Tello","journal-title":"Circ: Cardiovasc Imaging"},{"issue":"4","key":"R33","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1164\/rccm.202309-1692OC","article-title":"Machine learning of plasma proteomics classifies diagnosis of interstitial lung disease","volume":"210","author":"Huang","journal-title":"Am J Respir Crit Care Med"}],"container-title":["JMIR Medical Informatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medinform.jmir.org\/2025\/1\/e74117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:05:08Z","timestamp":1782842708000},"score":1,"resource":{"primary":{"URL":"https:\/\/medinform.jmir.org\/2025\/1\/e74117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":33,"URL":"https:\/\/doi.org\/10.2196\/74117","relation":{},"ISSN":["2291-9694"],"issn-type":[{"value":"2291-9694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"article-number":"v13i9e74117"}}